Crawley Clinical Commissioning Group (CCCG) and GlaxoSmithKline UK (GSK) Osteoporosis
Joint Working Summary
Crawley Clinical Commissioning Group (CCCG) and GlaxoSmithKline UK Limited (GSK UK Limited) working jointly to evaluate and subsequently improve the efficiency of osteoporosis care from the Fracture Liaison Service (FLS).
Benefits of the project to the patient will be to:
- Increase quality of care closer to home
- Improved continuity of care with the FLS
- High risk patients identified and receive appropriate treatment
- Better experience of the healthcare system
Start date – Oct 12
Finish date – To be confirmed
For further information contact
GSK UK Limited Customer contact no +44 (0) 800221441
UK/COM/0053/13(1) Archived 2015.